Silo Pharma (SILO) Competitors $0.74 -0.06 (-6.95%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$0.72 -0.02 (-2.48%) As of 09/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO vs. PMNT, EVKG, ONON, AS, LULU, LEVI, BIRK, GIL, KTB, and ZGNShould you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Perfect Moment (PMNT), Ever-Glory International Group (EVKG), ON (ONON), Amer Sports (AS), lululemon athletica (LULU), Levi Strauss & Co. (LEVI), Birkenstock (BIRK), Gildan Activewear (GIL), Kontoor Brands (KTB), and Ermenegildo Zegna (ZGN). These companies are all part of the "apparel" industry. Silo Pharma vs. Its Competitors Perfect Moment Ever-Glory International Group ON Amer Sports lululemon athletica Levi Strauss & Co. Birkenstock Gildan Activewear Kontoor Brands Ermenegildo Zegna Perfect Moment (NASDAQ:PMNT) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings. Which has more volatility & risk, PMNT or SILO? Perfect Moment has a beta of -3.42, suggesting that its share price is 442% less volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500. Do insiders & institutionals have more ownership in PMNT or SILO? 23.0% of Perfect Moment shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 2.2% of Silo Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to PMNT or SILO? In the previous week, Silo Pharma had 6 more articles in the media than Perfect Moment. MarketBeat recorded 6 mentions for Silo Pharma and 0 mentions for Perfect Moment. Silo Pharma's average media sentiment score of 1.23 beat Perfect Moment's score of 0.00 indicating that Silo Pharma is being referred to more favorably in the news media. Company Overall Sentiment Perfect Moment Neutral Silo Pharma Positive Is PMNT or SILO more profitable? Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,798.61%. Silo Pharma's return on equity of -94.39% beat Perfect Moment's return on equity.Company Net Margins Return on Equity Return on Assets Perfect Moment-67.38% -513.83% -119.38% Silo Pharma -6,798.61%-94.39%-68.62% Which has preferable valuation & earnings, PMNT or SILO? Silo Pharma has lower revenue, but higher earnings than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerfect Moment$22.00M0.77-$8.72M-$0.98-0.49Silo Pharma$70K100.19-$4.39M-$1.05-0.71 SummarySilo Pharma beats Perfect Moment on 8 of the 13 factors compared between the two stocks. Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SILO vs. The Competition Export to ExcelMetricSilo PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.54M$3.13B$5.74B$10.39BDividend YieldN/A2.39%5.75%4.64%P/E Ratio-0.7120.6375.7726.11Price / Sales100.19442.69544.59124.93Price / CashN/A44.6737.5461.24Price / Book0.669.6212.876.30Net Income-$4.39M-$52.73M$3.29B$271.03M7 Day Performance8.39%1.81%0.26%-0.14%1 Month Performance12.67%5.50%2.85%5.82%1 Year Performance-30.06%18.12%65.65%27.63% Silo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SILOSilo Pharma0.7823 of 5 stars$0.74-7.0%N/A-29.4%$7.54M$70K-0.712Gap UpPMNTPerfect MomentN/A$0.50+6.5%N/A-56.2%$15.78M$22.00M-0.3931EVKGEver-Glory International GroupN/A$0.00flatN/AN/A$10KN/A0.004,300ONONON4.1297 of 5 stars$42.97+0.7%$64.20+49.4%-12.4%$26.87B$2.63B95.493,254Positive NewsOptions VolumeASAmer Sports3.7454 of 5 stars$37.21-0.1%$41.62+11.9%+127.2%$20.63B$5.18B90.7613,400Gap DownLULUlululemon athletica4.6761 of 5 stars$162.34+1.5%$242.24+49.2%-33.8%$18.97B$10.59B11.0439,000Trending NewsAnalyst DowngradeLEVILevi Strauss & Co.3.4614 of 5 stars$22.54-0.2%$23.45+4.1%+9.3%$8.94B$6.36B22.1018,700Trending NewsUpcoming EarningsAnalyst ForecastBIRKBirkenstock3.7354 of 5 stars$45.60-1.1%$68.58+50.4%-9.1%$8.66B$1.96B25.337,400Trending NewsHigh Trading VolumeGILGildan Activewear4.4509 of 5 stars$54.68-0.4%$64.58+18.1%+20.7%$8.19B$3.27B17.3650,000Analyst RevisionKTBKontoor Brands4.3214 of 5 stars$80.05-2.4%$91.33+14.1%+0.5%$4.56B$2.61B17.8713,200Positive NewsZGNErmenegildo Zegna1.8227 of 5 stars$9.34-0.6%$9.28-0.7%+7.2%$3.83B$2.11B17.627,395News CoverageAnalyst ForecastGap Up Related Companies and Tools Related Companies Perfect Moment Competitors Ever-Glory International Group Competitors ON Competitors Amer Sports Competitors lululemon athletica Competitors Levi Strauss & Co. Competitors Birkenstock Competitors Gildan Activewear Competitors Kontoor Brands Competitors Ermenegildo Zegna Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SILO) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
